A case of severe psoriatic erythroderma with COVID-19.
J Dermatolog Treat
; 33(2): 1111-1113, 2022 Mar.
Article
in English
| MEDLINE | ID: covidwho-659162
ABSTRACT
COVID-19 caused by the SARS-CoV-2, became pandemic very quickly. Management of severe dermatologic disorders in patients who require systemic immunosuppressive treatment is a major concern in COVID-19 pandemic era. Here, we report a 45-year-old homeless addicted male with second flare of psoriatic erythroderma and positive PCR test for COVID 19. His first attack occurred two months earlier, when he was screened for SARS-CoV-2 before admission which all evaluations showed nagative results. The patient was treated and relatively controlled with cyclosporine and therefore he was discharged. During this interval, he not only discontinued his medication, but also became SARS-CoV-2 positive. It seems that both factors participated in flare of his erythroderma.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Dermatitis, Exfoliative
/
COVID-19
Type of study:
Case report
/
Experimental Studies
Topics:
Long Covid
Limits:
Humans
/
Male
/
Middle aged
Language:
English
Journal:
J Dermatolog Treat
Journal subject:
Dermatology
Year:
2022
Document Type:
Article
Affiliation country:
09546634.2020.1799918
Similar
MEDLINE
...
LILACS
LIS